APA (7th ed.) Citation

Oba, T., Long, M. D., Keler, T., Marsh, H. C., Minderman, H., Abrams, S. I., . . . Ito, F. (2020). Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s. Nature Portfolio.

Chicago Style (17th ed.) Citation

Oba, Takaaki, Mark D. Long, Tibor Keler, Henry C. Marsh, Hans Minderman, Scott I. Abrams, Song Liu, and Fumito Ito. Overcoming Primary and Acquired Resistance to Anti-PD-L1 Therapy by Induction and Activation of Tumor-residing CDC1s. Nature Portfolio, 2020.

MLA (8th ed.) Citation

Oba, Takaaki, et al. Overcoming Primary and Acquired Resistance to Anti-PD-L1 Therapy by Induction and Activation of Tumor-residing CDC1s. Nature Portfolio, 2020.